All content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.

Peptide register

Every peptide covered here, with its mechanism class, legal status and WADA status. This is a status register, not a shop: no suppliers, no doses, no efficacy claims.

Sort

Class

Legal status

WADA status

Monograph

9 of 73

Adamax

NeuropeptidesResearch chemical WADA · Prohibited (S0)

Synthetic analogue of the Semax peptide family; no registered human trials and no approval.

Monograph

Cerebrolysin

NeuropeptidesPrescription medicine

Peptide preparation from porcine brain tissue; approved prescription medicine in Austria and Russia.

Not approved in the US; national approvals only

Monograph planned

Delta Sleep-Inducing Peptide DSIP

NeuropeptidesResearch chemical WADA · Prohibited (S0)

Nonapeptide first described in the 1970s; no marketing authorisation in any market.

Monograph

Dihexa

NeuropeptidesResearch chemical WADA · Prohibited (S0)

Angiotensin IV-derived peptidomimetic; preclinical work only, no approval in any market.

Monograph planned

P21

NeuropeptidesResearch chemical WADA · Prohibited (S0)

Ciliary neurotrophic factor-derived peptide studied in rodents; no approval in any market.

Monograph planned

PE-22-28

NeuropeptidesResearch chemical WADA · Prohibited (S0)

Spadin-derived TREK-1 channel blocker peptide; preclinical only, no approval anywhere.

Monograph

Selank

NeuropeptidesPrescription medicine

Synthetic tuftsin analogue peptide; registered as a prescription medicine in Russia.

Russia only

Monograph

Semax

NeuropeptidesPrescription medicine

Synthetic ACTH (4-10) fragment analogue; registered as a prescription medicine in Russia.

Russia only

Monograph

VIP (vasoactive intestinal peptide) VIP

NeuropeptidesIn clinical development

Vasoactive intestinal peptide; the synthetic form aviptadil is studied but has no stand-alone approval.

Approved in some European countries only as part of a combination product

Monograph planned

Take myPeptides with you

Track doses, plans and progress on your phone — end-to-end encrypted.

This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.